arrow
K

Kyung Hee Park

Severance Hospital
H指数:39
被引数:4,841

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial

在韩国和泰国亚洲肥胖人群中每周一次使用2.4 mg司美格鲁肽(BMI ≥25 kg/m²)(STEP 11):一项随机、双盲、安慰剂对照的3期临床试验

2025-08-150
PRE
Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction

非严重药物超敏反应升级为过敏性休克的临床特征及危险因素

2025-04-220
OAAI
The KAAACI Guidelines for Sublingual Immunotherapy
2024-01-010
OAAI
KAAACI Guidelines for Allergen Immunotherapy
2023-01-019
OAAI